Effect of Text Message Reminders and Vaccine Reservations on Adherence to a Health System COVID-19 Vaccination Policy: A Randomized Clinical Trial.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 07 2022
01 07 2022
Historique:
entrez:
20
7
2022
pubmed:
21
7
2022
medline:
23
7
2022
Statut:
epublish
Résumé
Many organizations implemented COVID-19 vaccination requirements during the pandemic, but the best way to increase adherence to these policies is unknown. To evaluate if behavioral nudges delivered through text messages could accelerate adherence to a health system's COVID-19 vaccination policy. This randomized clinical trial was conducted within Ascension health system from October 11 to November 8, 2021. Participants included health system employees in the Midwest or South US who were not adherent with the vaccination policy 1 month before its deadline. Data were analyzed from November 17, 2021, to February 25, 2022. Participants were randomly assigned to control or to receive a text message intervention that stated a vaccine had been reserved for the participant, with a scheduled date for vaccination within a 2-week period. Participants could reschedule to a different date within the period or upload a copy of their vaccination card. Follow-up text message reminders were sent the day before and the day of the appointment. The primary outcome was adherence to the health system's vaccination policy during the 2-week intervention. Secondary outcomes included time to vaccination during a 4-week follow-up period. The sample included 2000 participants (mean [SD] age, 36.4 [12.3] years; 1724 [86.2%] women), with 1000 participants randomized to the control group and 1000 participants randomized to the intervention group. Overall, there were 164 Hispanic participants (8.2%), 46 non-Hispanic Asian participants (2.3%), 202 non-Hispanic Black participants (10.1%), and 1418 non-Hispanic White participants (70.9%). By the end of the 2-week intervention, 363 participants in the text message nudge group (36.3%) and 318 participants in the control group (31.8%) were adherent with the vaccination policy, representing a significant increase of 4.9 (95% CI, 0.8 to 9.1) percentage points in adjusted analyses comparing the nudge group with the control group (P = .02). Among participants who became adherent by the end of the 4-week follow-up period, the text message nudge significantly reduced time to adherence by a mean of 2.4 (95% CI, 2.1 to 4.7) days (P < .001) and a median of 5.0 (95% CI, 2.5 to 7.7) days (P < .001) compared with the control group. At 4 weeks, overall vaccination adherence was no longer different between groups (control: 477 participants [47.7%]; intervention: 472 participants [47.2%]). This randomized clinical trial found that a behavioral nudge delivered through text messages accelerated adherence to a health system's COVID-19 vaccination policy but did change overall adherence by the time of the policy deadline. ClinicalTrials.gov Identifier: NCT05037201.
Identifiants
pubmed: 35857327
pii: 2794447
doi: 10.1001/jamanetworkopen.2022.22116
pmc: PMC9301516
doi:
Substances chimiques
COVID-19 Vaccines
0
Vaccines
0
Banques de données
ClinicalTrials.gov
['NCT05037201']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2222116Références
JAMA Netw Open. 2021 Dec 1;4(12):e2138238
pubmed: 34882179
JAMA Netw Open. 2020 Dec 1;3(12):e2033324
pubmed: 33337490
N Engl J Med. 2021 Jul 1;385(1):e1
pubmed: 34038633
JAMA. 2021 Feb 9;325(6):532-533
pubmed: 33372955
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
JAMA. 2021 Aug 24;326(8):766-767
pubmed: 34213530
BMJ Glob Health. 2021 Sep;6(9):
pubmed: 34593513
N Engl J Med. 2018 Jan 18;378(3):214-216
pubmed: 29342387
Nature. 2021 Feb;590(7845):185
pubmed: 33564188
Nature. 2021 Sep;597(7876):404-409
pubmed: 34340242
Proc Natl Acad Sci U S A. 2021 May 18;118(20):
pubmed: 33926993
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
JAMA. 2010 Jul 7;304(1):43-4
pubmed: 20606147